SYRS
Syros Pharmaceuticals, Inc. · Healthcare
Aisling Capital III LP bought $5.0M of Syros Pharmaceuticals, Inc.
10% owner
Bought$5,000,000
$12.50Price
400,000Shares
+79%Stake
What SYRS did for a copier
Prices for SYRS after this filing aren't in yet.
Aisling Capital III LP's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Jul 6. Filed Wed, Jul 6, 1:10 PM ET, during the session. Not investment advice.